acetaminophen; ibuprofen · Aft Pharms Us · NDA 209471
Combogesic
Earliest generic entry, as listed
27 Feb 2039
Blocked by patent: US 11197830, US 11534407.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11197830 | product, use U-3553 | 27 Feb 2039 |
| US 11534407 | product, use U-3553 | 27 Feb 2039 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 25 Oct 2026Generic approved · 209471-00111 Dec 2025
- 25 Oct 2026Generic approved · 209471-0012 Jan 2026
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 209471 · 001 · RLD | tablet, oral | 325MG;97.5MG | 27 Feb 2039 |
Expired or delisted (1)
- NP · 1 Mar 2026